Genindex-prodindex.xls

SUBJECT TITLE
VOLUME NO
ACETAZOLAMIDE TABS - FUNGAL CONTAMINATION ADMINISTRATION -RESPONSIBILITIES FOR SAFE ADRENALINE - PACKAGING OF PRE-FILLED SYRINGES ALFACALCIDOL - LABELLING AND OVERDOSE INCIDENTS ALUMINIUM CONTAMINATION OF CALCIUM GLUCONATE AMPHOTERICIN - SOLUTION ON RECONSTITUTION ANAESTHETIC MACHINES AND OXYGEN ANALYSERS ASCORBIC ACID - NON PL TABLETS POOR QUALITY ASEPTIC PREPARATION - FINAL CHECKING ISSUES ASPARAGINASE - PARTICLES AFTER RECONSTITUTION ATROPHINE - ADRENALINE SYRINGE IN CRASH BOX BENADRYL - CONFUSION OF ACTIVE INGREDIENTS BETAMETHASONE - INCOMPATIBILITY WITH COAL TAR BETAMETHASONE EYE DROPS - USE AFTER OPENING BRAND NAMES - CONFUSION OF ACTIVE INGREDIENTS BUDESONIDE (PULMICORT RESPULES) LABELLING CANCER CHEMOTHERAPY: FOR BETTER FOR WORSE REPORT CHLORMETHIAZOLE SYRUP - STORAGE TEMPERATURE CIPROFLOXACIN SUSPENSION - LABELLING ISSUES CLINICAL TRIALS - IMPLEMENTATION OF EC DIRECTIVE CLINOMEL - CONTENTS MIXING BEFORE INTENDED USE CLINOMEL - CONTENTS MIXING BEFORE INTENDED USE CO-CARELDOPA TABS - DOWELHURST PARALLEL IMPORT COLD CHAIN MONITORING/FRIDGE TEMPERATURES COLOMYCIN - SHELF LIFE AFTER RECONSTITUTION COMPLIANCE ISSUES LABELLING & PACKAGING COMPLIMENTARY AND NATURAL HEALTHCARE COUNCIL CONTACT LENS SOLNS - ACANTHAMOEBA KERATITIS COTRIMOXAZOLE - PRECIPITATION OF INJECTION COUNSELLING - CODE OF ETHICS REQUIREMENTS CYCLOPENTOLATE EYE DROPS - PACKAGING PROBLEMS CYCLOPHOSPHAMIDE - RECONSTITUTION DIRECTIONS CYTARABINE INJECTION - STRENGTH CONFUSIONS CYTOTOXIC DRUGS - HEALTH AND SAFETY ISSUES DIPHTHERIA VACCINE - EXPIRY DATE CONFUSION DIPTHERIA & TETANUS VACCINE - LABELLING DISCONTINUED MEDICINES - BEST PRACTICE GUIDELINES DOXORUBICIN - DILUENT FOR RECONSITITUTION ERTHROMYCIN SUSPENSION - VOLUME AFTER RECONSTITUTIO ETOMIDATE - POTENTIAL MIX-UP WITH PROPOFOL EXTEMPORANEOUS DISPENSING - YELLOW COVERED DOCUME FLECAINIDE INJ - GLASS FRAGMENTS WHEN AMPS OPENED FLUCLOXACILLIN SYRUP - FAILURE TO DISSOLVE FLUPHENAZONE INJECTION LABELLING CONFUSION FLUROURACIL - MORE REPORTS OF CRYSTAL PRESENT FRESUBIN EASY BAGS - MICROBIAL CONTAMINATION FRESUBIN EASY BAGS - MICROBIAL CONTAMINATION GELOFUSINE - DIFFICULTIES WITH GIVING SETS & LEAKING BAG GEMCITABINE - RECONSTITUTION INSTRUCTIONS GENERICS - MODIFIED RELEASE PREPARATIONS HAZARDS/RISKS IN DISPENSARIES (EDITORIAL) HEARING AID LOOP SYSTEM - N&N HOSPITAL HUMAN IMMUNOGLOBULIN - RECONSTITION PROBLEMS INFUSION BAGS - WATER LOSS DURING STORAGE INFUSIONS - PLASTIC PARTICLES CONTAMINATION INJECTIONS - LABELLING OF SYRINGES IN THEATRES INJECTIONS - PREPARATION IN CLINICAL AREAS INNOVATIONS - ALTERNATIVE TO FREEZE DRYING INTRATHECAL INJECTIONS INVOLVING CHEMOTHERAPY ISOSORBIDE MONONITRATE - LABEL DEFECT/RECALL LABELLING AND PACKAGING - CSM WORKING GROUP LEAFLETS - PILs NOT AVAILABLE FOR SOME PRODUCTS LICENCE ISSUES - IMPORTED DRUGS (EDITORIAL) LIGNOCAINE DENTAL CARTRIDGES - STORAGE REQUIREMENTS MAGNESIUM SULPHATE - EXPRESSION OF STRENGTH MEDICAL DEVICE ALERTS - NEW GUIDANCE DOCUMENT MEDICAL GASES - SAFETY ISSUES WITH MRI EQUIPMENT MEDICAL GASES - TESTING PIPED GAS INSTALLATIONS MEDICAL GASES - YELLOW COLOURATION OF FILTERS MEDICATION ERRORS - LEARNING FROM MISTAKES MEDICATION ERRORS - LOOK-ALIKE AND SOUND-ALIKE NAMES MEDICATION ERRORS - MICROGRAM/MILLIGRAM CONFUSION MEDICATION ERRORS - PACKAGING AND LABELLING ISSUES MEDICINE HELPLINE - PETERBOROUGH HOSPITAL MEDROXYPROGESTERONE INJ - EXTRACTABLE VOLUME METHOTREXATE TABLETS - STRENGTH CONFUSION METRONIDAZOLE - CONFUSION OF COMPATIBILITIES METRONIDAZOLE - LABELLING OF SUPPOSITORIES METRONIDAZOLE INJECTION - LABELLING CONFUSION MICRO ORGANISMS - SURVIVAL IN HOSTILE ENVIRONMENTS MITOMYCIN - SHELF LIFE AFTER RECONSTITUTION MITOMYCIN - STABILITY AFTER RECONSTITUTION NHS 50TH ANNIVERSARY - PATIENT ENPOWERMENT (EDITORIAL NOMENCLATURE - NAME CONFUSION (EDITORIAL) NORADRENALINE - LABELLING OF IMPORTED INJECTION NOSOCOMIAL INFECTION AND CIVAS (EDITORIAL) ONCOLOGY PHARMACY & CHEMOTHERAPY STANDARDISATION ORGANOPHOSPHATE POISONING - PRALIDOXIME MESYLYTATE OVERLABELLING - OBSCURING ESSENTIAL INFORMATION PAPWORTH HOSPITAL - QUALITY IMPROVEMENT INITIATIVES PATIENT PERCEPTIONS - SERVICE QUALITY (EDITORIAL) PENTOSTAM, PENTOSAN, PENTOSTATIN NAME CONFUSION PHENOL INJECTION IN ALMOND OIL - LABEL ISSUE POTASSIUM CHLORIDE SOLN - DILUTION REQUIREMENTS POVIDONE IODINE VAGINAL GEL - APPLICATOR PROBLEMS PRESCRIBING FOR CHILDREN - OFF-LABEL ISSUES PRESCRIPTION WRITING - LEGIBILITY/COMPUTERS PROCHLORPERAZINE - TABLET COLOUR VARIATION PRODUCT LICENCES/MARKETING AUTHORISATIONS NUMBERS PROPOFOL - INCOMPATIBILITY WITH VYGON LINES QUALITY MATTERS 100TH EDITION (EDITORIAL) SAFETY - RSI AND OTHER OCCUPATIONAL HAZARDS SALBUTAMOL - LABELLING OF BLOW FILL SEAL SODIUM CHLORIDE - NORMOSOL SACHETS - CONCENTRATION SODIUM CHLORIDE INJECTION - EXPRESSION OF STRENGTH SODIUM CHLORIDE INJECTION - EXPRESSION OF STRENGTH SODIUM CHLORIDE UROTAINERS - USER PROBLEMS STANDARDS - PERVERSE INCENTIVES (EDITORIAL) STAVUDINE ORAL SOLUTION - LABELLING CONFUSION STERILE MANUFACTURE/PREPARATION OCCUPATIONAL SYRINGE HUBS - LEAKING MULTI-ADD (BRAUN) BRAND TEICOPLANIN - PRECIPITATION OF RECONSTITUTED INJECTION TEICOPLANIN - STABILITY OF RECONSTITUTED INJECTION TPN - ALGORITHM FOR FORMULATION STABILITY TPN - INTRAVENOUS CATHETERS WITH NEONATES UNLICENSED MEDICINES - LOCAL TRUST POLICIES UNLICENSED MEDICINES - PATIENT AWARENESS ISSUES UNLICENSED MEDICINES PATIENT AWARENESS OF STATUS VALIDATION, CHANGE CONTROL & CAPACITY PLANNING VERIFICATION OF CHEMOTHERAPY PRESCRIPTIONS VINCA ALKALOIDS - DOH REPORT FOLLOWING NOTTINGHAM FAT VINCRISTINE ADMINISTRATION GUIDELINES (EDITORIAL) VIPER VENOM ANTISERUM - DOSE INSTRUCTIONS

Source: http://www.nhsped.uea.ac.uk/assets/v2/documents/genindex-prodindex.pdf

hkupop.hku.hk

Press Release 50% women think a woman can have at least 2 sex partners in her lifetime Open-minded in sex yet lack sound contraception knowledge Specialist urges the adoption of contraceptives Hong Kong single women are increasingly open-minded on sex due to higher education, better job prospect, and stronger financial power. A survey conducted by the University of Hong Kong ha

11_04contents

Volume 373 · Number 9671 · April 11–17, 2009 The Lancet—London Editorial Articles 1253 Zoledronic acid and risedronate in the prevention and 1224 Care for vulnerable migrants in the UKtreatment of glucocorticoid-induced osteoporosis double-dummy, randomised controlled trial The Lancet—New York 1225 Glucocorticoid-induced osteoporosis: hope on the 1264

© 2008-2018 Medical News